Global CD38 Monoclonal Antibody Drugs Market Research Report 2021

1 CD38 Monoclonal Antibody Drugs Market Overview

• 1.1 Product Overview and Scope of CD38 Monoclonal Antibody Drugs
• 1.2 CD38 Monoclonal Antibody Drugs Segment by Type
  • 1.2.1 Global CD38 Monoclonal Antibody Drugs Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Daretuzumab
  • 1.2.3 Isartuximab
  • 1.2.4 Engineered Toxin Body
• 1.3 CD38 Monoclonal Antibody Drugs Segment by Application
  • 1.3.1 Global CD38 Monoclonal Antibody Drugs Sales Comparison by Application: (2021-2027)
  • 1.3.2 Multiple Myeloma
  • 1.3.3 Diffuse Large B Cell Lymphoma
  • 1.3.4 Other
• 1.4 Global CD38 Monoclonal Antibody Drugs Market Size Estimates and Forecasts
  • 1.4.1 Global CD38 Monoclonal Antibody Drugs Revenue 2016-2027
  • 1.4.2 Global CD38 Monoclonal Antibody Drugs Sales 2016-2027
  • 1.4.3 CD38 Monoclonal Antibody Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 CD38 Monoclonal Antibody Drugs Market Competition by Manufacturers

• 2.1 Global CD38 Monoclonal Antibody Drugs Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global CD38 Monoclonal Antibody Drugs Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers CD38 Monoclonal Antibody Drugs Manufacturing Sites, Area Served, Product Type
• 2.5 CD38 Monoclonal Antibody Drugs Market Competitive Situation and Trends
  • 2.5.1 CD38 Monoclonal Antibody Drugs Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest CD38 Monoclonal Antibody Drugs Players Market Share by Revenue
  • 2.5.3 Global CD38 Monoclonal Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 CD38 Monoclonal Antibody Drugs Retrospective Market Scenario by Region

• 3.1 Global CD38 Monoclonal Antibody Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global CD38 Monoclonal Antibody Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America CD38 Monoclonal Antibody Drugs Market Facts & Figures by Country
  • 3.3.1 North America CD38 Monoclonal Antibody Drugs Sales by Country
  • 3.3.2 North America CD38 Monoclonal Antibody Drugs Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe CD38 Monoclonal Antibody Drugs Market Facts & Figures by Country
  • 3.4.1 Europe CD38 Monoclonal Antibody Drugs Sales by Country
  • 3.4.2 Europe CD38 Monoclonal Antibody Drugs Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific CD38 Monoclonal Antibody Drugs Market Facts & Figures by Region
  • 3.5.1 Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Region
  • 3.5.2 Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America CD38 Monoclonal Antibody Drugs Market Facts & Figures by Country
  • 3.6.1 Latin America CD38 Monoclonal Antibody Drugs Sales by Country
  • 3.6.2 Latin America CD38 Monoclonal Antibody Drugs Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
• 3.7 Middle East and Africa CD38 Monoclonal Antibody Drugs Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Country
  • 3.7.2 Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global CD38 Monoclonal Antibody Drugs Historic Market Analysis by Type

• 4.1 Global CD38 Monoclonal Antibody Drugs Sales Market Share by Type (2016-2021)
• 4.2 Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Type (2016-2021)
• 4.3 Global CD38 Monoclonal Antibody Drugs Price by Type (2016-2021)

5 Global CD38 Monoclonal Antibody Drugs Historic Market Analysis by Application

• 5.1 Global CD38 Monoclonal Antibody Drugs Sales Market Share by Application (2016-2021)
• 5.2 Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Application (2016-2021)
• 5.3 Global CD38 Monoclonal Antibody Drugs Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Johnson
  • 6.1.1 Johnson Corporation Information
  • 6.1.2 Johnson Description and Business Overview
  • 6.1.3 Johnson CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Johnson CD38 Monoclonal Antibody Drugs Product Portfolio
  • 6.1.5 Johnson Recent Developments/Updates
• 6.2 Sanofi
  • 6.2.1 Sanofi Corporation Information
  • 6.2.2 Sanofi Description and Business Overview
  • 6.2.3 Sanofi CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Sanofi CD38 Monoclonal Antibody Drugs Product Portfolio
  • 6.2.5 Sanofi Recent Developments/Updates
• 6.3 Takeda Pharmaceutical Company
  • 6.3.1 Takeda Pharmaceutical Company Corporation Information
  • 6.3.2 Takeda Pharmaceutical Company Description and Business Overview
  • 6.3.3 Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Product Portfolio
  • 6.3.5 Takeda Pharmaceutical Company Recent Developments/Updates
• 6.4 CASI Pharmaceutical Company
  • 6.4.1 CASI Pharmaceutical Company Corporation Information
  • 6.4.2 CASI Pharmaceutical Company Description and Business Overview
  • 6.4.3 CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Product Portfolio
  • 6.4.5 CASI Pharmaceutical Company Recent Developments/Updates
• 6.5 Mab Biopharma
  • 6.5.1 Mab Biopharma Corporation Information
  • 6.5.2 Mab Biopharma Description and Business Overview
  • 6.5.3 Mab Biopharma CD38 Monoclonal Antibody Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Mab Biopharma CD38 Monoclonal Antibody Drugs Product Portfolio
  • 6.5.5 Mab Biopharma Recent Developments/Updates

7 CD38 Monoclonal Antibody Drugs Manufacturing Cost Analysis

• 7.1 CD38 Monoclonal Antibody Drugs Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of CD38 Monoclonal Antibody Drugs
• 7.4 CD38 Monoclonal Antibody Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 CD38 Monoclonal Antibody Drugs Distributors List
• 8.3 CD38 Monoclonal Antibody Drugs Customers

9 CD38 Monoclonal Antibody Drugs Market Dynamics

• 9.1 CD38 Monoclonal Antibody Drugs Industry Trends
• 9.2 CD38 Monoclonal Antibody Drugs Growth Drivers
• 9.3 CD38 Monoclonal Antibody Drugs Market Challenges
• 9.4 CD38 Monoclonal Antibody Drugs Market Restraints

10 Global Market Forecast

• 10.1 CD38 Monoclonal Antibody Drugs Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of CD38 Monoclonal Antibody Drugs by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of CD38 Monoclonal Antibody Drugs by Type (2022-2027)
• 10.2 CD38 Monoclonal Antibody Drugs Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of CD38 Monoclonal Antibody Drugs by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of CD38 Monoclonal Antibody Drugs by Application (2022-2027)
• 10.3 CD38 Monoclonal Antibody Drugs Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of CD38 Monoclonal Antibody Drugs by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of CD38 Monoclonal Antibody Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List